AR065916A1 - Composicion farmaceutica que comprende la combinacion de un agente antiartritico, un agente condroprotector y un agente antiinflamatorio - Google Patents
Composicion farmaceutica que comprende la combinacion de un agente antiartritico, un agente condroprotector y un agente antiinflamatorioInfo
- Publication number
- AR065916A1 AR065916A1 ARP080101371A ARP080101371A AR065916A1 AR 065916 A1 AR065916 A1 AR 065916A1 AR P080101371 A ARP080101371 A AR P080101371A AR P080101371 A ARP080101371 A AR P080101371A AR 065916 A1 AR065916 A1 AR 065916A1
- Authority
- AR
- Argentina
- Prior art keywords
- agent
- pharmaceutical composition
- combination
- active substance
- antiarthritic
- Prior art date
Links
- 239000002260 anti-inflammatory agent Substances 0.000 title abstract 2
- 229940121363 anti-inflammatory agent Drugs 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229940124346 antiarthritic agent Drugs 0.000 title 1
- 239000003435 antirheumatic agent Substances 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 3
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 abstract 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 abstract 1
- 229920001287 Chondroitin sulfate Polymers 0.000 abstract 1
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 abstract 1
- 208000025747 Rheumatic disease Diseases 0.000 abstract 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 abstract 1
- 229940059329 chondroitin sulfate Drugs 0.000 abstract 1
- 239000003042 chondroprotective agent Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229960002442 glucosamine Drugs 0.000 abstract 1
- 229960001929 meloxicam Drugs 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 239000011885 synergistic combination Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/009—Sachets, pouches characterised by the material or function of the envelope
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Una composicion farmacéutica compuesta por la combinacion sinérgica de un agente ntiartrítico, como lo es el principio activo: Sulfato de Condroitina, un agente condroprotector, como lo es el principio activo: Glucosamina y una agenteantiinflamatorio, como lo es el principio activo: Meloxicam, los cuales se encuentran formulados en una sola unidad de dosificacion para ser administrada por vía oral en forma de polvo para solucion con presentacion en sobres monodosis, mismos queestán indicados para el tratamiento de enfermedades tales como: osteoartritis, artritis reumatoide, artrotis y cualquier otra enfermedad reumática relacionada.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2007003947A MX2007003947A (es) | 2007-04-02 | 2007-04-02 | Composicion farmaceutica que comprende la combinacion de un agente antiartritico, un agente condroprotector y un agente antiinflamatorio. |
| PCT/MX2008/000010 WO2008120965A1 (es) | 2007-04-02 | 2008-01-29 | Composición farmaceutica que comprende la combinación de un agente antiartrítico, un agente condroprotector y un agente antiinflamatorio. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR065916A1 true AR065916A1 (es) | 2009-07-08 |
Family
ID=39808486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080101371A AR065916A1 (es) | 2007-04-02 | 2008-04-01 | Composicion farmaceutica que comprende la combinacion de un agente antiartritico, un agente condroprotector y un agente antiinflamatorio |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR065916A1 (es) |
| CL (1) | CL2008000963A1 (es) |
| MX (1) | MX2007003947A (es) |
| WO (1) | WO2008120965A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR067447A1 (es) * | 2008-07-03 | 2009-10-14 | Monte Verde S A | Un procedimiento para preparar una composicion farmaceutica que contiene los proincipios activos glucosamina y meloxicam y el uso de dicha asociacion para el tratamiento de patologias degenerativas osteo-articulares |
| WO2022250523A1 (es) * | 2021-05-26 | 2022-12-01 | Garcia Perez, Miguel Angel | Productos, kits farmacéuticos y sus usos que comprenden un precursor directo en la formación de glicosaminoglicanos y un fármaco antiinflamatorio no esteroideo como composiciones independientes |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050101563A1 (en) * | 2001-08-14 | 2005-05-12 | Pharmacia Corporation | Method and compositions for the treatment and prevention of pain and inflammation |
| US8512727B2 (en) * | 2003-03-03 | 2013-08-20 | Alkermes Pharma Ireland Limited | Nanoparticulate meloxicam formulations |
| RU2260432C1 (ru) * | 2004-10-12 | 2005-09-20 | Открытое Акционерное Общество "Нижегородский Химико-Фармацевтический Завод" (Оао "Нижфарм") | Средство для лечения болезней суставов |
-
2007
- 2007-04-02 MX MX2007003947A patent/MX2007003947A/es not_active Application Discontinuation
-
2008
- 2008-01-29 WO PCT/MX2008/000010 patent/WO2008120965A1/es not_active Ceased
- 2008-04-01 AR ARP080101371A patent/AR065916A1/es unknown
- 2008-04-02 CL CL200800963A patent/CL2008000963A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008120965A1 (es) | 2008-10-09 |
| CL2008000963A1 (es) | 2008-09-12 |
| MX2007003947A (es) | 2009-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2619309T3 (es) | Ácido hialurónico sulfatado para el tratamiento de la osteoartritis degenerativa | |
| PE20130690A1 (es) | Tratamiento de artritis reumatoide con una combinacion de laquinimod y metotrexato | |
| UY33546A (es) | Corticosteroides para el tratamiento del dolor de las articulaciones | |
| PE20130496A1 (es) | Tratamiento de artritis por lupus usando laquinimod | |
| CL2012002318A1 (es) | Compuestos derivados de tieno [2,3-d]pirimidina, inhibidores de quinasa mnk1 y mnk2; composición farmaceutica; que los comprende; y su uso en el tratamiento de enfermedades metabolicas, hematopoyeticas, neurodegenerativas, renales, inflamatorias y cancer. | |
| UY32989A (es) | Coposiciones terapéuticas concentradas de fosfolípidos | |
| AR084781A1 (es) | Composiciones que comprenden y metodos que utilizan inhibidores de los cotransportadores de sodio-glucosa 1 y 2 | |
| BR112014014341A2 (pt) | Intermediário metilado, seu método de preparação e seus usos, e composição farmacêutica | |
| CL2008002999A1 (es) | Uso de una composicion farmeceutica que comprende trns-clominefo para preparar un medicamenteo util en el ratamiento de recuccion de los niveles de glucosa en ayunas en un varon. | |
| BRPI0907414A2 (pt) | forma oral de dosagem farmacêutica contendo pelo menos dois medicamentos | |
| AR068820A1 (es) | Composicion farmaceutica que comprende la combinacion de diversos agentes venotonicos y vasoprotectores para el tratamiento de la insuficiencia venosa cronica y uso | |
| AR081082A1 (es) | Composiciones organicas para tratar enfermedades relacionadas con beta-enac | |
| AR065916A1 (es) | Composicion farmaceutica que comprende la combinacion de un agente antiartritico, un agente condroprotector y un agente antiinflamatorio | |
| UY31097A1 (es) | Composicion farmaceutica que comprende la combinacion de un agente antiinflamatorio no esteroideo y un agente anticonvulsionante | |
| ECSP067074A (es) | Derivados de 4-fenil-pirimidina-2-carbonitrilo | |
| CO6602160A2 (es) | Terapia de b12 oral | |
| BR112015008964A2 (pt) | composições injetáveis estáveis contendo diclofenaco e tiocolquicosídeo | |
| BR112013028872A2 (pt) | composição para uso no tratamento por via oral de infecções dentárias; forma farmacêutica para administração oral | |
| AR081007A1 (es) | Combinacion farmaceutica caracterizada porque comprende ibuprofeno y l-arginina | |
| ECSP10010053A (es) | Composición farmacéutica compuesta por la combinación de sulfato de condroitina y diacereina y su uso en el tratamiento de la osteoartritis y enfermedades relacionadas | |
| AR074521A1 (es) | Asociacion de ingredientes activos que contienen un farmaco antiinflamatorio, no esteroideo y un derivado de colchicosido | |
| AR067465A1 (es) | Composicion farmaceutica que comprende la combinacion de un agente derivado benzisoxazolico y un agente benzodiazepinico | |
| ES2468665B1 (es) | Composición farmacéutica de sulfato de condroitina y celecoxib | |
| UY31230A1 (es) | Composición farmacéutica que comprende la combinación de un agente anticonvulsionante y un agente benzodiazepínico, indicada para el control y tratamiento de trastornos convulsivos y síndromes epilépticos. | |
| PE20090316A1 (es) | Composicion farmaceutica que comprende la combinacion de un agente antimicrobiano y un agente antioxidante para el tratamiento de infecciones urinarias |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |